Would you be interested in helping us with this article focused on FcRn inhibitors for people with the neuromuscular disorder myasthenia gravis? 

I am looking for a consumer who would be willing to provide feedback for a Cochrane protocol, "FcRn inhibitors for myasthenia gravis". Cochrane considers a consumer to be a person with experience of the condition (in this case, myasthenia gravis), either as a patient or as a carer/family member of a patient. 

A protocol is a plan for a systematic review. Consumer input at protocol stage is integral to ensure that the completed systematic review will be helpful to patients and carers with healthcare decision making. For consumer peer review, you will be asked to complete a short form with your feedback. Our aim is for this to be a manageable task, that does not overburden consumer reviewers.   

Thank you in advance for considering!